Commonwealth Bank: Pleasing with positive read-throughs
About the author:
- Author name:
- By Azib Khan
- Job title:
- Former Senior Analyst
- Date posted:
- 10 February 2021, 3:00 PM
- Sectors Covered:
- Commonwealth Bank of Australia (ASX:CBA) has reported cash NPAT of $3,975m, 3.9% better than our expectation. An interim dividend of $1.50 per share fully franked has been declared.
- The result is pleasing with positive read-throughs for the other major banks.
Listen to the podcast here
Good operating income outcome has positive read-throughs
CBA’s 1H21 operating income is 2.2% better than we expected. The 1H21 net interest margin (NIM) of 2.01% is in line with our expectations.
While we continue to expect the low interest rate environment and the front to back book mortgage pricing impact to remain substantial NIM headwinds in 2H21F, we see enough offsetting tailwinds (discussed inside) such that we expect the NIM to remain broadly stable.
There is good momentum in home lending at the moment with CBA calling out December and January as particularly strong months for volumes.
CBA’s domestic business lending (excluding institutional lending) growth of 4% over 1H21 was better than we expected.
CBA also posted strong Markets income in the Dec-20 quarter. The strong Markets outcome and strong home loan growth over the Dec-20 quarter bode well for upcoming Dec-20 quarter trading updates from the other major banks.
Credit impairment charge pleases
CBA’s loan loss rate has reduced from 48bps in 2H20 to 28bps in 1Q21 to 17bps in 2Q21; this downtrend bodes well for the upcoming Dec-20 quarter trading updates from the other major banks and we expect consensus credit impairment charge forecasts for FY21 to be reduced in the aftermath of these trading updates.
CBA increased its collective provision coverage of credit risk weighted assets from 156bps at Sep-20 to 158bps at Dec-20, a move which we view as being conservative given improvement in the macroeconomic outlook.
Were it not for this top-up, the loan loss rate for the Dec-20 quarter would have been even lower.
As we expected, CBA is remaining conservative with provisioning as it awaits the impact of the roll-off of temporary fiscal stimulus measures and as it awaits commencement of a vaccine roll out in Australia and New Zealand.
CET1 ratio exceptionally strong
CBA’s CET1 ratio of 12.6% as at Dec-20 is sitting very strong relative to APRA’s ‘unquestionably strong’ benchmark of 10.5%. A further 32-42bps of CET1 uplift is expected from completion of announced divestments.
Previously, CBA’s base case scenario for adverse credit risk weighted asset (CRWA) migration involved a ~70bps adverse impact on the CET1 ratio; however, this impact has now been revised to zero under the base case scenario.
We have consequently favourably revised our CRWA inflation forecasts for CBA and there is now an increased likelihood of making similar revisions to our CRWA forecasts for the other major banks in due course.
We are now forecasting off-market share buybacks for CBA of $5bn in FY22F and $5bn in FY23F.
Investment view and changes to forecasts
We have increased our cash EPS forecasts by 3.5%/2.4%/6.0% for FY21F/FY22F/FY23F respectively.
We retain a Reduce recommendation. Our target price, based on our DDM valuation, increases from $64.00 (login to view target price).
Find out more
Download full research note
You can find further detailed analysis of company results this reporting season by browsing our reporting season tag, and view a full list of upcoming results on our Reporting Season Calendar.
If you would like access or more information, please contact your adviser or nearest Morgans office.
Request a call
Find local branch
Need access to our research?
You are also welcome to start a two-week trial of our online platform, which provides access to detailed market analysis and insights, provided by our award-winning research team.
Create trial account
Disclaimer: The information contained in this report is provided to you by Morgans Financial Limited as general advice only, and is made without consideration of an individual's relevant personal circumstances. Morgans Financial Limited ABN 49 010 669 726, its related bodies corporate, directors and officers, employees, authorised representatives and agents (“Morgans”) do not accept any liability for any loss or damage arising from or in connection with any action taken or not taken on the basis of information contained in this report, or for any errors or omissions contained within. It is recommended that any persons who wish to act upon this report consult with their Morgans investment adviser before doing so.